Bank of New York Mellon Corp Sells 12,337 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Bank of New York Mellon Corp cut its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.2% in the 1st quarter, HoldingsChannel reports. The fund owned 372,507 shares of the company’s stock after selling 12,337 shares during the quarter. Bank of New York Mellon Corp’s holdings in Prestige Consumer Healthcare were worth $32,024,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in PBH. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in Prestige Consumer Healthcare in the 4th quarter valued at about $84,932,000. Raymond James Financial Inc. bought a new stake in Prestige Consumer Healthcare during the fourth quarter worth about $42,593,000. Norges Bank bought a new position in Prestige Consumer Healthcare during the fourth quarter valued at approximately $40,009,000. Bessemer Group Inc. increased its holdings in Prestige Consumer Healthcare by 10,053.1% during the fourth quarter. Bessemer Group Inc. now owns 295,050 shares of the company’s stock valued at $23,041,000 after buying an additional 292,144 shares during the last quarter. Finally, Natixis Advisors LLC increased its stake in shares of Prestige Consumer Healthcare by 1,335.1% in the fourth quarter. Natixis Advisors LLC now owns 209,246 shares of the company’s stock worth $16,340,000 after purchasing an additional 194,665 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Down 1.7%

Shares of Prestige Consumer Healthcare stock opened at $75.10 on Wednesday. The business has a fifty day simple moving average of $83.52 and a 200 day simple moving average of $82.34. The company has a quick ratio of 2.82, a current ratio of 4.20 and a debt-to-equity ratio of 0.55. The stock has a market cap of $3.71 billion, a PE ratio of 17.51, a price-to-earnings-growth ratio of 2.29 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 12 month low of $64.94 and a 12 month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. The firm had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the company posted $1.02 EPS. Research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Ratings Changes

Several research firms recently commented on PBH. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a “hold” rating in a research note on Thursday, May 8th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.